Found 364 clinical trials
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.
- 0 views
- 14 Mar, 2022
- 2 locations
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer
This phase I trial evaluates the effects of CBM588 in combination with standard therapies, nivolumab and cabozantinib, in treating patients with kidney cancer that has spread to other places in the body (advanced/metastatic). The digestive microbiome may have an effect on how patients respond to treatment, and previous research shows …
- 0 views
- 14 Mar, 2022
- 1 location
IPG7236 in Patients With Advanced Solid Tumors
This is a Phase 1, Multi-center, Non-randomized, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of IPG7236 Administered Orally as a Single Agent in Patients with Advanced Solid Tumors. The study will include a dose escalation phase (Part 1) and a dose …
- 0 views
- 14 Mar, 2022
- 1 location
- 0 views
- 18 Nov, 2024
- 1 location
Bevacizumab2
Trial Level -> Patient Prescreener is enabledProgram level -> Call Center Prescreener is enabled
- 0 views
- 02 Mar, 2026
- 1 location
MagnetisMM-20 Enrolling people with Multiple Myeloma
A clinical trial to learn about the effects of combined treatments for multiple myeloma that has returned or not responded to previous treatment
- 0 views
- 21 Jan, 2025
- 2 locations